BSE filing, NSE: NATCAPSUQ. Summary written from the filing by ALFA Finder's alert engine.
Natural Capsules Ltd: key numbers
- Share price
- ₹136.50
- Market cap
- ₹142.1 Cr
- Revenue (annual)
- ₹187.2 Cr
- Net profit (annual)
- ₹-24.66 Cr
- P/E (TTM)
- -6.6×Sector 46.5×
- Promoter holding
- 50.92%+0.00% QoQ
- FII holding
- 0.08%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Natural Capsules Ltd
All →Natural Capsules Annual General Meeting
Natural Capsules Ltd dispatched a corrigendum to its upcoming EGM notice, revising the issue price and quantity for the proposed preferential allotment of shares and warrants.
Natural Capsules Fund Raise of ₹10.01 Cr
Natural Capsules Limited approved a revised preferential issue of 1,12,500 equity shares and 4,50,000 convertible warrants. The total aggregate fund raise is valued at Rs. 10.01 Crore.
- Value
- ₹10.01 Cr
Natural Capsules Board Meeting Date
Natural Capsules Limited is holding a board meeting at shorter notice on September 02, 2026, to revise the issue price and quantity for its proposed preferential issue.
Natural Capsules Annual General Meeting
Natural Capsules Limited has issued a notice for an EGM to approve a Rs. 10.00 Crore preferential allotment of equity shares and warrants to a promoter.
- Value
- ₹10.00 Cr
Natural Capsules Investor Presentation: Key Takeaways
NCL reported Q1FY27 revenue of ₹48.71 Cr (+8% Y-o-Y) with EBITDA at ₹1.12 Cr. Strategy focuses on scaling steroidal API volumes and HPMC line conversions to optimize capacity.
Natural Capsules Results Update
Natural Capsules Limited announced its Q1FY27 financial results. The company highlighted operational performance, market demand, and new contract manufacturing agreements for its business segments.
Other management change announcements
All →Sayaji Hotels (Indore) Management Change
Sayaji Hotels (Indore) appointed Azhar Yusuf Dhanani as Additional Non-Executive Non-Independent Director effective October 28, 2026. Shareholder approval is required within three months.
Fabtech Technologies Management Change
FABTECH Technologies appointed Mr. Alan Dias as Vice President - HR, a senior management personnel role, effective October 28, 2026. He brings over 24 years of human resources experience.
Parmax Pharma Management Change
Parmax Pharma's independent director Ami Shah resigned effective October 28, 2026. The exit follows a change in management and control of the company.
Sagarsoft (India) Management Change
Sagarsoft (India) appointed Ms. Arcot Ganeshan Monisha as Company Secretary and Compliance Officer, designated as KMP, effective 28 October 2026. Details are provided per Regulation 30 in the annexure.
Chemfab Alkalis Management Change
Chemfab Alkalis approved unaudited Q2/H1 results, committee re-designations, and appointed V. R. Raguraman as Chief Operating Officer (SMP). The senior management appointment is the filing's main business event.
Aeroflex Industries Management Change
Aeroflex Industries reports Drashti Bhil's change from Deputy CFO to CFO, plus Mustafa Kachwala's tenure completion as CFO effective 27 November 2026. Management reshuffle with no money or business event.